Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 26

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax

Wang, Tao, Lee, Kyunghee, Rehman, Abdur, Daoud, Sayed S. · 2007 · Biochemical and Biophysical Research Communications

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbrc.2006.11.006

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 27

  1. Vogelstein, 2000, Surfing the p53 network, Nature (Lond.), 408, 30710, 10.1038/35042675 · DOI · Paper page
  2. Colman, 2000, Regulation of p53 stability and activity in response to genotoxic stress, Mutat. Res., 462, 179, 10.1016/S1383-5742(00)00035-1 · DOI · Paper page
  3. Daoud, 2003, Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study, Cancer Res., 63, 2782
  4. Lai, 2000, Mutations in the p53 tumor suppressor gene and early onset breast cancer, Cancer Biol. Ther., 1, 231
  5. Bull, 2004, The combination of p53 mutation and neu/erbB2 amplification is associated with poor survival in node-negative breast cancer, J. Clin. Oncol., 22, 86, 10.1200/JCO.2004.09.128 · DOI
  6. Selivanova, 1998, Reactivation of mutant p53: a new strategy for cancer therapy, Semin. Cancer Biol., 8, 369, 10.1006/scbi.1998.0099 · DOI
  7. Chipuk, 2003, Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription, Cancer Cell, 4, 371, 10.1016/S1535-6108(03)00272-1 · DOI · Paper page
  8. Wang, 2006, PRIMA-1-induces apoptosis in p53 mutant breast cancer cell lines by inhibiting the JNK cell survival pathway and promoting the activation of proapoptotic p53 targets Bax and PUMA, Proc. AACR, 47, 2214
  9. Rehman, 2005, Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells, Breast Cancer Res., 7, R765, 10.1186/bcr1290 · DOI
  10. Miled, 2005, A genomic map of p53 binding sites identifies novel p53 targets involved in an apoptotic network, Cancer Res., 65, 5096, 10.1158/0008-5472.CAN-04-4232 · DOI
  11. Redkar, 2004, Implication of p53 in growth arrest and apoptosis induced by combined treatment with topotecan and UCN-01 in human mammary epithelial cells, J. Exp. Ther. Oncol., 4, 213
  12. Appella, 2000, Signaling of p53: breaking the posttranslational modification code, Pathol. Biol. (Paris), 48, 227
  13. Stewart, 2001, Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell specific manner, Oncogene, 20, 113, 10.1038/sj.onc.1204060 · DOI
  14. Bean, 2001, Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV, Oncogene, 20, 1076, 10.1038/sj.onc.1204204 · DOI
  15. Wang, 2003, Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding, Mol. Cell. Biol., 23, 2171, 10.1128/MCB.23.6.2171-2181.2003 · DOI · Paper page
  16. Unger, 1999, Mutations in serines 15 and 20 of human p53 impair its apoptotic activity, Oncogene, 18, 3205, 10.1038/sj.onc.1202656 · DOI · Paper page
  17. Wang, 2003, Phosphorylation and hsp90 binding mediate heat shock stabilization of p53, J. Biol. Chem., 278, 2066, 10.1074/jbc.M206697200 · DOI
  18. Kaeser, 2002, Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo, Proc. Natl. Acad. Sci. USA, 99, 95, 10.1073/pnas.012283399 · DOI · Paper page
  19. Yao, 1999, HGK that specifically activates the c-Jun-N-terminal kinase signaling pathway, J. Biol. Chem., 274, 2118, 10.1074/jbc.274.4.2118 · DOI · Paper page
  20. Weston, 2002, The JNK signal transduction pathway, Curr. Opin. Genet. Dev., 12, 14, 10.1016/S0959-437X(01)00258-1 · DOI · Paper page
  21. Lin, 2002, Activation of the JNK signaling pathway: breaking the brake on apoptosis, BioEssays, 25, 17, 10.1002/bies.10204 · DOI · Paper page
  22. Potapova, 2000, Inhibition of c-Jun N-terminal kinase-2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner, Mol. Cell. Biol., 20, 1713, 10.1128/MCB.20.5.1713-1722.2000 · DOI
  23. Shaulian, 2002, AP-1 as a regulator of cell life and death, Nat. Cell Biol., 4, E131, 10.1038/ncb0502-e131 · DOI · Paper page
  24. Liu, 2005, Role of JNK activation in apoptosis: a double-edged sword, Cell Res., 15, 36, 10.1038/sj.cr.7290262 · DOI · Paper page
  25. Lee, 2006, Expression proteomics to p53 mutation reactivation with PRIMA-1 in breast cancer cells, Biochem. Biophys. Res. Commun., 349, 1117, 10.1016/j.bbrc.2006.08.152 · DOI
  26. Li, 2006, Essential role of c-Jun-NH2-terminal kinase on synergy induction of apoptosis by TRAIL plus ADM in ADM resistant MCF-7/ADM cells, Apoptosis, 11, 1239, 10.1007/s10495-006-7494-8 · doi:10.1007/s10495-006-7494-8
  27. Hsu, 2006, Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo, J. Pharmacol. Exp. Ther., 318, 484, 10.1124/jpet.105.098863 · DOI · Paper page

Cited by

See all 26

Metadata

Authors
Wang, T., Lee, K., Rehman, A., & Daoud, S. S.
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
2007-01
Volume
352
Issue
1
Pages
203-212
ISSN
0006-291X
Cited by
26
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.